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Objective: Osteoporotic fractures impose a huge economic burden on society. Though several cost of illness
studies from other countries exist, no equivalent study has been conducted in Austria. Our study aims at assessing
costs resulting from osteoporotic fractures in Austria in the year 2008 from a societal perspective.
Methods: We took both direct and indirect costs into consideration. Direct costs encompass medical costs such as
expenses for pharmaceuticals, inpatient and outpatient medical care costs, as well as other medical services (e.g.,
occupational therapies). Non-medical direct costs include transportation costs and medical devices (e.g., wheel
chairs or crutches). Indirect costs refer to costs of productivity losses due to absence of work. Moreover, we
included costs for early retirement and opportunity costs of informal care provided by family members. For our
analysis, we combined data of official statistics, expert estimates as well as unique patient surveys that are currently
conducted in the course of an international osteoporotic fracture study in Austria.
Results: For the year 2008, the total annual financial burden incurred by osteoporotic fractures in Austria amounted
to approx. €685.2 million, the largest fraction of which was due to the opportunity cost of family care (30.2%),
followed by costs for hospitalization (26.6%).
Conclusions: The financial burden of osteoporotic fractures in Austria is substantial. Our findings may have
implications for future economic analyses, and also support health care authorities in their decision making.
Keywords: Burden of illness, Costs of illness, Osteoporosis, AustriaBackground
Osteoporosis is defined as a „systemic skeletal disease
characterized by low bone mass and microarchitectural
deterioration of bone tissue with a consequent increase
in bone fragility and susceptibility to fracture” [1]. The
average lifetime risk in a 50 year old person to experi-
ence an osteoporotic fracture has been estimated at 40-
50% for women and at 13-22% for men [2]. Accordingly,
it has been estimated that in the year 2000 some 9 mil-
lion osteoporotic fractures have occurred worldwide, in-
cluding 1.6 million hip fractures, 1.7 million forearm
fractures, and 1.4 million clinical (symptomatic) verte-
bral fractures [3]. These major osteoporotic fractures
have been shown to be associated with significant mor-
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in any medium, provided the original work is pto be associated even with excess mortality [4]. Further-
more, the combined annual costs of all osteoporotic
fractures have been estimated to be $20 billion in the
United States and €30 billion in the European Union, in-
dicating that in addition to morbidity and mortality,
osteoporotic fractures are also associated with a signifi-
cant financial burden to the society [5].
Assessment of the national financial burden of osteo-
porosis is usually undertaken by means of cost-of-illness
studies [6], and several of such have been conducted
throughout a number of countries worldwide, particu-
larly in countries of the so called Western World [7-12].
However, the majority of these studies have primarily
focused on costs occasioned by hip fractures, since
national data on the epidemiology of this type of frac-
ture are more likely to be readily accessible than data
from any other type of osteoporotic fracture [3,4,6].
Furthermore, due to differences in healthcare systems,
approaches utilized to estimate the number of fracturesn Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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types and qualities of data as well as computations,
results of cost-of-illness studies among different coun-
tries can hardly be compared [6]. However, irrespective
of such uncertainties, it has been widely accepted that
osteoporotic fractures impose a huge economic burden
worldwide, with a trend towards further increases [6].
Austria counted some 8.3 million inhabitants at the
beginning of 2008. Similar to many other European
countries, Austria’s age pyramid at the beginning of the
twenty-first century shows a narrow base due to a reduc-
tion in birth-rates, whereas the percentage of the senior
population 50 years of age and older, is increasing.
Within the elderly Austrian population, the number of
women clearly exceeds the number of men which is due
not only to the higher life expectancy of women, but also
to the large number of men who died in World War II.
The incidence of osteoporotic fractures in the Austrian
population has been estimated to be among the highest
worldwide [13]. For example, in 2008 the total number
of hip fractures in the population 50 years and above
was 15,615, with an age-standardized incidence of hip
fractures for the female population of 605 per 100.000,
and an age-standardized incidence of hip fractures in the
according male population of 261 per 100.000 [13]. Con-
sequently, it has been hypothesized that the financial
burden of osteoporotic fractures in Austria must be
substantial.
The aim of the present study was to estimate the fi-
nancial burden of osteoporotic fractures in the Austrian
population, including fractures of the hip, vertebrae, dis-
tal forearm, humerus, and ribs.
Methods
Direct and indirect costs
To estimate the financial burden, both direct and indir-
ect costs related to osteoporotic fractures have been
considered, except costs for rehabilitation. Direct costs
in general encompass medical as well as non-medical
costs directly related to the causative disease. Accord-
ingly, we included costs for pharmacotherapy, hospital
and nursing home, as well as costs for (follow-up) radio-
graphs, wheel chairs, crutches, transport to outpatient
settings etc. In contrast, indirect costs, sometimes also
referred to as productivity costs, are a measure of
present and/or future productivity losses caused by a
disease. Indirect costs were calculated according to the
human capital approach [14]. Hence, we included prod-
uctivity loss due to absence from work as well as costs
for early retirement and costs of informal (unpaid) care
provided by family members and/or other persons. We
decided to draw on the human capital approach rather
than on the friction-cost method because the former is
grounded in neoclassical economic theory while thelatter is not [15]. Moreover, Austria’s unemployment rate
in 2008 was among the lowest in Europe. This fact
served as an additional argument to not employ the fric-
tion cost approach in our study. Only in case of labour
market imperfections and high unemployment the fric-
tion cost approach might be considered as a feasible
alternative.Source and quantity of costs following fracture
Source and quantity of costs following the first year
after fracture have been obtained from the Austrian
branch of the International Costs and Utilities Related
to Osteoporotic Fractures Study (ICUROS). The
ICUROS is an ongoing international study supported
by the International Osteoporosis Foundation (IOF)
which aims at assessing the consequences of osteopor-
otic fractures in terms of costs and health related
quality of life (QOL) in a standardized form, making
results comparable among the different participating
countries worldwide [data unpublished, http://www.
medscinet.com/icuros/project.aspx]. To assess sources
and quantities of costs for the prevailing study, an in-
terim analysis of the Austrian study arm of the
ICUROS was performed. Data were extracted from a
total of 916 patients who had finished phase II of the
study, i.e. who had at least one follow-up interview
within the first year after the fracture. Of these
patients, 488 had a hip fracture, 158 had a clinical ver-
tebral fracture, 140 had distal forearm fracture, and
122 had a fracture of the humerus. Information on fol-
lowing parameters was obtained: Number of outpatient
visits at the primary care level and/or hospital, number
of home visits, number of phone counselling, use and
dosage of drugs, number and type of community ser-
vices and other services (e.g. nursing), information on
working situation, type of employment (also part or
full-time), number of sick days, informal care, informa-
tion on investments directly or indirectly caused by
fracture and its consequences (wheelchair, walking aids,
modifications to house/apartment, special utensils for
personal hygiene etc.).
Depending on the source of costs, costs themselves
where then obtained from institutions and services
which most likely would have readily accessible the
according information.Number of patients with osteoporotic fractures
The number of patients with osteoporotic fractures
was calculated for the entire Austrian population. The
following types of fracture were included: hip fracture,
humeral fracture, clinical (symptomatic) vertebral frac-
ture, distal forearm fracture, and rib fracture. Since
most but not all of the fractures may have been due
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been applied [11].
Hip fractures
The number of patients with hip fractures in Austria in
2008 was obtained from the Austrian Hospital Discharge
Register (AHDR) for the entire population. As one hun-
dred percent of people who sustain a hip fracture are ad-
mitted to hospitals, the number obtained from the
AHDR is equivalent to the total number of patients who
sustained a hip fracture in 2008. To correct for possible
multiple registrations (within a year after admission) for
the same diagnosis, a correction factor (0.9) has been ap-
plied. These data have been published recently [13].
Humeral fractures
The number of patients with humeral fractures admitted
to hospitals in Austria in 2008 has been drawn from the
AHDR. In contrast to patients who sustain a fracture of
the hip, only a part of those who sustain a humeral frac-
ture are admitted to hospitals. The proportion of
patients who have been treated in an outpatient setting
was assessed by extracting databases from seven large
Trauma Units in Austria who covered about 20% of all
humeral fractures that occurred in 2008 nationwide.
Based on the data obtained from these Trauma Units, it
has been estimated that the proportion of humeral frac-
ture patients who have been admitted to hospitals (and
hence captured by the AHDR) is 57%. An according cor-
rection factor was applied.
Clinical vertebral fractures
The number of patients with clinical vertebral fractures
who have been admitted to hospitals in Austria in 2008
was derived from the AHDR. However, since not all
patients with clinical vertebral fractures are admitted to
hospitals, this number would reflect only part of the
total number of patients. According to data derived from
a recently published Swedish study, it was estimated that
the number of patients with clinical vertebral fractures
admitted to hospitals account for approximately 10% of
all female patients with clinical vertebral fractures, and
15% of all male patients nationwide [16]. To estimate
the total number of Austrian patients who sustained a
clinical vertebral fracture, an according correction factor
was applied.
Forearm fractures
The number of patients with forearm fractures who have
been admitted to hospitals in Austria in 2008 was derived
from the AHDR. Again, this number would reflect only
part of the total number of patients who had sustained a
forearm fracture, since many of these patients may be
treated in an outpatient setting. Several studies haveindicated that in general only approximately 20% of
patients with distal forearm fractures are admitted to
hospitals and treated in an inpatient setting, e.g. for the
purpose of operative intervention [17-19]. To estimate
the total number of Austrian patients who sustained a
forearm fracture, the according correction factor was
applied.
Rib fractures
The number of patients with rib fractures who have
been admitted to hospitals in 2008 in Austria was
derived from the AHDR. Again, this number would re-
flect only part of the total number of patients who had
sustained a rib fracture that came to clinical attention
[20]. In a Finnish population it has been estimated that
only about 10% of all rib fractures after minimal trauma
would be admitted to hospitals [21]. To estimate the
total number of Austrian patients with low trauma rib
fractures, the according correction factor was applied.
Costs of hospitalization
Data on the average duration of stay in hospital per frac-
ture type (i.e. hip, clinical vertebral, humerus, forearm,
ribs) was obtained from the ICUROS, and/or provided
by Statistics Austria. To estimate the total number of
days of stay in hospital, the number of days of stay in
hospitals per fracture type was multiplied by the number
of patients who had sustained an according fracture
under consideration of correction factors where applic-
able (see above), and results obtained from the different
fracture types were then summarized.
Data on costs per day of stay in hospital were provided
by the Austrian Federal Ministry of Health. In average,
in 2008 the cost of one day spent in an orthopaedic or
trauma department of an Austrian Hospital was € 592
(including medications, nutrition etc.). This value was
then multiplied by the total calculated hospital days of
stay which have been caused by osteoporotic fractures.
Costs of outpatient treatment
Costs incurred through consultations of practicing and/
or hospital employed specialists (e.g. orthopaedists) were
calculated using data provided by the Central Association
of Austrian Social Security Institutions. In average, costs
for consultation of an orthopaedist in a hospital out-
patient clinic were € 53.55 per consultation, and costs for
consultation of an orthopaedist in the primary care set-
ting were € 73.10 per consultation. These costs were then
multiplied by the according number of consultations.
Other medical and non-medical costs
Number of radiographs, physical therapies and transpor-
tation as consequences of a fracture were obtained from
the ICUROS database. Unit costs for radiographs, bone
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ometry [DXA]) and physical therapy were provided by
the Central Association of Austrian Social Security Insti-
tutions. Average unit cost of BMD-measurement (lum-
bar spine and hip) was estimated at € 35.00. Average
unit cost of a radiograph was estimated at € 80.40, and
the average unit cost of a standard physical therapy was
estimated at € 30.00. Information on costs of non-
emergency transportation was provided by a common
Austrian Ambulance Service (Samariterbund). Mean
cost per transportation was estimated at € 57.00. Unit
cost for wheelchairs, wheeled walkers, crutches, ramps,
cranes etc. were obtained through information provided
by the according retail stores.
Costs of pharmacotherapy
Costs of pharmacotherapy were calculated based on the
estimated number of incident osteoporotic fractures in
Austria in 2008. However, since data from the Austrian
study arm of the ICUROS indicates that only about 22%
of patients with recent osteoporotic fracture would re-
ceive adequate osteoporosis treatment (data unpub-
lished), estimation of costs of pharmacotherapy only
took into account this proportion of patients. Further-
more, to further improve accuracy of estimation, we also
considered the proportional distribution of osteoporosis
drugs as derived from the ICUROS database. For estima-
tion of costs incurred by analgesics, calcium and vitamin
D, again data from the ICUROS were extracted which
indicated that ~37% of patients following an osteopor-
otic fracture would receive analgesic therapy, and 40%
would receive calcium and vitamin D. Drug prices were
based on the 2008 version of the Austrian EKO (Erstat-
tungskodex) [22].
Costs of nursing and informal care
Number of hours of nursing care and informal care as a
consequence of osteoporotic fracture was obtained from
the Austrian ICUROS database. Information on costs of
nursing was provided by Statistics Austria, and the aver-
age cost of one hour of nursing was estimated at € 30.
Information on number of hours of informal (unpaid)
care provided by family members or other persons as a
consequence of osteoporotic fracture was obtained from
the Austrian ICUROS database. Cost of one hour of in-
formal care was estimated at € 27.50, reflecting the aver-
age hourly wage of an Austrian employee [23].
Costs of absenteeism
Data regarding number and costs of sick-days due to
osteoporotic fractures in the Austrian population were
provided by Statistics Austria and the Austrian Pension
Insurance Authority. In total, 3.490 men and 2.336
women had been on sick-leave due to such conditions in2008. The average number of sick-days in these patients
was 16.3 in men, and 18.9 in women. To estimate the
costs of absenteeism, the mean annual gross salary per
capita of Austrian employees was divided by 220 work-
ing days, and this number was then multiplied by the
average number of osteoporotic-fracture associated sick-
days. However, it should be considered that the costs
estimated as described above, would rather underesti-
mate the true costs, as wages alone would not include
for example loss of profit or the employer’s contribution
to the Austrian Social Security institutions. Therefore, to
estimate the total loss of added value incurred through
absenteeism, data from the official Input–output Table
(IOT) were extracted. Data were provided by Statistics
Austria. By means of this analysis, information on so
called second round effects was obtained. Second round
effects typically occur due to reduced productivity in
one company or institution (e.g. caused by absenteeism
of employees), with the consequence of decreasing out-
put in supplying companies or institutions [24].
Costs of early retirement
According to data provided by the Federal Ministry of
Labour, Social Affairs and Consumer Protection, as well
as Statistics Austria, a total of 338.462 Austrians were
registered as in early retirement due to disability (also
referred to as disability pension) in 2008 [25], and
25.146 cases of early retirement have been newly regis-
tered throughout the year 2008. The average annual cost
of early retirement per capita in 2008 was €13.395. Mus-
culoskeletal and connective tissue diseases have been the
underlying cause in 6.989 cases, of whom 0.338% was
due to osteoporosis-related conditions [25]. Accordingly,
the total number of disability pension cases due to
osteoporosis-related conditions in 2008, was estimated
at approximately 1.444. To calculate the total costs of
early retirement due to osteoporosis-related conditions,
the estimated number of cases was multiplied with the
average annual costs per capita to come up with an esti-
mated amount of € 19.3 million.
Results
The total cost of osteoporotic fractures in Austria from
a societal perspective is € 685.6 million (Table 1). The
two biggest cost drivers are the opportunity costs of
family care and the cost of hospitalization. The cost of
absenteeism in early retirement is rather low which
reflects the fact that most patients suffering from an
osteoporotic fracture have already left the labour market
before the fracture has occurred.
Number of fractures
In 2008, an estimated total of 119,911 patients with inci-
dent osteoporosis-related fractures were treated in










Nursing care 67.0 9.8%




Indirect costs Costs of absenteeism 40.1 5.8%
- foregone wages −13.3 −1.9%
- loss of added value
(e.g. profit, social insurance
contributions etc.)
−26.7 −3.9%
Early retirement 19.3 2.8%
Family care 207.3 30.2%
TOTAL 685.6 100%
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fracture (12%), 23,934 (20%) a forearm fracture, 9,573
(8%) a humeral fracture, 39,028 (33%) a clinical vertebral
fracture, and 32,505 (27%) a rib fracture. For lack of rele-
vant data, morphometric vertebral fractures were not
included in our study. Overall, 91,067 cases (76%) were
first treated in an outpatient setting, and 28,844 cases
(24%) in an inpatient setting.
Bed days
Mean bed days per fracture type was 15.7 for hip frac-
ture, 4.3 for forearm fracture, and 6.1 for humeral, clin-
ical vertebral, and rib fractures (Table 2). The estimated
total number of bed days for all fractures was 308,219.
Inpatient costs were € 182.4 million, accounting for
about 45% of direct costs, and 27% of total costs,
respectively.
Number of visits
The total number of visits (not including the primary
visit following fracture) to private practice offices and
hospital outpatient clinics for all fractures was 252,229
and 306,127, respectively (Table 2). Mean number of vis-
its to private practice offices and hospital outpatient
clinics for all fractures was 1.7 and 2.5, respectively.
Total costs of visits to private practice offices were €
18,375,371.6, and total costs of visits to hospital out-
patient clinics were € 16,393,100.85, accounting for 5.8%
of overall cost.
Other medical and non-medical services
214,958 physical therapy sessions have been utilized fol-
lowing hip fracture, 266,306 following forearm fracture,202,176 following humeral fracture, 323,828 following
clinical vertebral fracture, and 271,214 following rib frac-
ture (Table 2). In total, 1,278,482 physical therapy ses-
sions have been utilized throughout 2008 as a direct
consequence of osteoporotic fractures. Total costs of all
physical therapy sessions due to osteoporotic fractures
were € 38.4 million, representing 5,6% of overall cost.
An estimated 32,305 x-rays have been taken following
hip fracture, 96.835 x-rays following forearm fracture,
18,323 x-rays following humeral fracture, 83,582 x-rays
following clinical vertebral fracture, and 73,154 x-rays
following rib fracture (Table 2). The estimated total
number of x-rays as a consequence of osteoporotic frac-
tures was 304,199. Total costs of all x-rays taken as a
consequence of osteoporotic fractures were € 24.5 mil-
lion, accounting for 3.6% of overall cost. It should be
noted though that for lack of data, follow-up MRT’s or
CT’s have not been included in our study, making it very
likely that true costs have rather been higher than shown
in this study.
The number of transportation services required as a
consequence of fracture was 11,429 for hip fracture,
16,613 for forearm fracture, 746 for humeral fracture,
16,803 for clinical vertebral fracture, and 15,176 for rib
fracture (Table 2). In total, 60,766 units of transportation
services have been utilized. Total costs of transportation
services utilized as a consequence of osteoporotic frac-
tures were € 3.5 million, accounting for 0.5% of overall
cost.
Pharmacotherapy
A total of 22.4% of patients received adequate
osteoporosis-specific treatment, which is a very low
share from a medical point of view. Patients were treated
with either alendronate (12%), risedronate (3.6%), iban-
dronate (3.6%), zoledronate (1.4%), parathyroid hormone
(0.6%; including both teriparatide and 1–84 PTH),
Raloxifene (0.4%), strontium ranelate (0.4%), or calci-
tonin nasal-spray (0.4%) (Table 3). Proportional cost of
analgesic treatment was estimated at € 3,354,145, and
costs of calcium and vitamin D treatment (without
patients treated with alendronate or risedronate) at €
2,185,350. Overall, estimated cost of pharmacotherapy
was € 17,920,047, accounting for 2.7% of total costs.
Nursing care and informal care
Average number of nursing care hours per case was 83
hours for hip fracture, 14 hours for forearm fracture, 25
hours for humeral fracture, and 38 hours for clinical ver-
tebral fracture Table 4. The total number of nursing care
hours as a consequence of osteoporotic fractures was
3,232,453. Total costs of nursing care hours were esti-
mated at € 97.0 million, thus accounting for 9.8% of
overall cost. The average number of family care hours
Table 2 Number of fractures, number and costs of bed days, visits, medical and non-medical services
Hip Forearm Humerus Clinical vertebral Rib Total









0 0 4,390 15,555 1,348 4,744 11,930 23,550 15,900 13,650 91,067




16.6 14.8 3.7 4.9 5.21 71 5.21 71 5.21 71 7,7
Total bed days 56,689 169,549 3,249 15,244 4,004 18,977 6,202 16,482 8,268 9,555 308,219









5,703 29,442 1,738 15,866 1,123 13,568 28,871 74,347 38,478 43,093 252,229
Costs of visits to
private practice
offices (€)3








5,430 14,549 30,712 96,130 3,113 12,748 31,495 44,298 41,976 25,676 306,127
Costs of visits to
hospital outpatient
clinics (€)4
290,776.5 779,098.95 1,644,627.6 5,147,761.5 166,701.15 682,655.4 1,686,557.25 2,372,157.9 2,247,814.8 1,374,949.8 16,393,100.85








54,230 160,728 21,968 244,338 53,225 148,951 110,889 212,939 147,791 123,423 1,278,482
Costs of physical
therapy (€)5




2.18 2.,17 3.5 4.2 1.33 2.08 2.5 1.96 2.5 1.96 2.43
X-rays
(total number)
7,445 24,860 18,438 78,397 2,817 15,506 32,808 50,774 43,725 29,429 304,199
Costs of
X-rays (€)6
598,578 1,998,744 1,482,415 6,303,118 226,486.8 1,246,682.4 2,637,763 4,082,229 3,515,490 2,366,091 24,457,599
BMD
Measurement7








0.73 0.78 — 0.89 — 0.1 0.55 0.37 0.55 0.37 0.43
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142,101 509,352 — 946,941 — 42,522 411,426 546,345 548,340 316,692 3,463,719
1 mean values for ICD-10 codes S10-S51, S53-S71, S73-S81.
2 Cost per bed day = € 592.
3 Cost per visit to private practice office (specialist) = € 73.10.
4 Cost per visit to hospital outpatient clinics (speacialist) = € 53.55.
5 Cost per session of physical therapy = € 30.
6 Cost per unit (i.e. X-ray) = € 80.40.
7 In average, 31% of Austrian patients received BMD measurment within first year after fracture (ICUROS-Austria).
8 Cost per BMD measurement (spine and hip).
9 Average cost per unit (i.e. per ride, as invoiced by a typical Ambulance service) = € 57.00.
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forearm fracture, 84 hours for humeral fracture, and 81
hours for clinical vertebral fracture. The total number of
family care hours was 7,536,660. Estimated total costs of
(informal) family care hours were € 207.3 millions,
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Numbers and costs of absenteeism are only related to
patients who have not yet retired. In 2008, 5,816 persons
have been on sick leave due to osteoporotic fractures,
with a mean duration of 16.3 days in men, and 18.9 days
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D tablets already included in price).
Table 4 Costs of nursing care, informal care, and special aids/equipment
Hip Forearm Humerus Clinical
vertebral
Rib1 Costs €
m f m f m f m f m f
Nursing care
Mean number of nursing
care hours per case
108 58 0 14 0 25 17 59 ———— ———— ————
Total number of
nursing care hours
368,820 664,448 0 261,324 0 186,375 223,091 1,528,395 ———— ———— 3,232,453
Total costs (€)2 11,064,600 19,933,440 0 7,839,720 0 5,591,250 6,692,730 45,851,850 ———— ———— 96,973,590
Informal (family care)
Mean number of family
care hours per case
199 130 0 32 5 163 51 111 ———— ———— —————
Total number of
family care hours
according to fracture type
679,585 1,489,280 0 597,312 10,590 1,215,165 669,273 2,875,455 ———— ———— 7,536,660
Total costs (€)3 18,688,588 40,955,200 0 16,426,080 291,225 33,417,038 18,405,008 79,075,013 ———— ———— 207,258,151
Special aids and equipment (crutches, wheel-chair etc.)
Mean expenses
(€) per case
49,00 111,67 0,00 5,00 0,00 79,59 31,75 69,88 ———— ———— 34,7
Total expenses (€) 167,335 1,279,292 0 93,330 0 593,343 416,655 1,810,241 ———— ———— 4,360,196
1 No data available from the ICUROS.
2 Estimated cost per hour of nursing care = € 30.
3 Estimated cost per hour of family care = € 27.50.
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plied by the average daily income of € 128.11 this results
to total costs of € 3.3 million €. The 100,841 sick leave
days induced a total loss of added value of € 40.1 mil-
lion, according our calculations based on the official
Austrian Input–output table.Discussion
This study provides for the first time realistic estimates
on the burden of different osteoporosis-related fractures
in Austria indicating a substantial financial impact for
the Austrian society in the year 2008 with a total burden
of more than €685 million. With regard to direct costs,
26.6% of all costs (approx. €183 million) were spent on
hospitalisation, followed by ambulatory care (13%, i.e.
€93.4 million), and pharmacotherapy (12%, i.e. approx.Table 5 Costs of absenteeism
Men Women All
Persons on sick leave due to
osteoporotic fractures
3,490 2,326 5,816
Mean duration (days) 16.3 18.9 17.6
Total days 56,887 43,961 100,848
Mean gross annual income (€) 35,325 21,041 28,183
Daily income
(€ year/220 working days)
160.57 95.65 128.11
Costs of absenteeism (€) 9,134,346 4,204,869.6 13,339,215€85 million). 34% of the total costs comprise indirect
costs with estimates of informal care being the biggest
part (26%, i.e. approx. €186 million). Osteoporosis is also
associated with costs due to lost economic value-added
which amounts to approx. €40 million.
Although costs of osteoporotic fractures have also
been estimated in other cost-of-illness studies, these esti-
mates cannot be directly compared because of differ-
ences in resource use and patterns of care as well as
different price levels of the treatment of fractures. How-
ever, these studies confirm that with respect to direct
costs, the most costly fractures are hip fractures followed
by vertebral fractures [26-28].
Our study, which also took into account nursing and
informal care costs derived from the ICUROS data on
utilisation of these resources, shows that vertebral frac-
tures are associated with the highest proportion of these
cost factors, which is in line with the results from the
KOFOR study [27].
Most published studies on costs of osteoporosis used
only hospitalization rates and applied internationally
accepted attribution factors [7,10,28-32], but this ap-
proach underestimates the total burden of this disease.
To minimize deficiencies inherent in under-diagnosis
we not only used information drawn from the national
hospital discharge register and Statistics Austria but
also international data of estimations on the outpatient
utilisation of resources due to osteoporotic fractures.
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the fact that a “real world” estimation regarding the
proportion of patients who would be treated after hav-
ing experienced an osteoporotic fracture in Austria was
applied. These estimations have been based on the find-
ings from the ICUROS, in which it was clearly demon-
strated that in Austria, irrespective of innumerable
awareness programmes that have been performed in the
past, only about 22% of those who experience an osteo-
porotic fracture would receive an adequate pharmaco-
logical treatment.
There are, however, several methodological issues to
be considered in interpreting the results of our study.
Although it is mandatory for all hospitals in Austria to
record discharge diagnoses by using the code classes of
the International Classification of Diseases (ICD-10), it
is possible that patients have multiple registrations for
the same diagnosis. Based on this, Dimai et al. used a
correction factor of 0.9 to adjust the incidence calcula-
tions for hip fractures in Austria [13]. Since there is no
information available on age group specific correction
factors for other types of fracture than hip, no correction
factor was used for these types of fracture.
Another limitation of our study may be the method
used to estimate those fractures, which are only par-
tially treated in hospitals. For instance, it has been
estimated that only one in three of those who experi-
ence a vertebral fracture will come to medical atten-
tion [33]. From these, as shown in a Swedish study,
only approximately 10% would be hospitalized [16].
Furthermore, treatment of distal forearm fractures is
highly variable in different centres in Austria. While
some prefer surgical treatment others prefer casting,
which is done on an outpatient basis. Likewise, high
geographical variations have been noted in inter-
national studies on the prevalence of different osteo-
porotic fractures. With this in mind, our multiplication
factors, which were taken according to results from
several other national studies, may actually either over-
or underestimate the total rates of the different frac-
tures due to osteoporosis in Austria.
Unfortunately, our study has not been designed to in-
clude costs for rehab. However, we believe that this limi-
tation of our study would not impose a significant bias,
since e.g. in Germany only 4% of total expenses are in-
curred by rehabilitation costs [12].
In contrast to the high expenditures, significant pro-
gress in the treatment and prevention of osteoporosis
has been achieved in the past two decades with the de-
velopment of different compounds with a proven effect
on bone mineral density and reduction of fracture risk
[34-36].
Despite of this, approximately 50% of patients do not
follow their prescribed treatment regimen and/ordiscontinue treatment within one year [37]. Poor com-
pliance is not only associated with higher fracture rates
but also increased morbidity, mortality, and costs
[38,39]. Likewise, a German study has shown that only
22% of osteoporotic patients have received treatment;
and moreover, 58% (daily dosing) and 43% (weekly dos-
ing) of these patients terminate their treatment [12].
Even though these medications are only indicated in
patients with a fracture risk of more than 30%, these
numbers reflect a high degree of unawareness and
under-treatment of osteoporosis. This has also been
shown in a recent Austrian study in nursing homes and
senior’s residences, where more than 20% of the patients
had a diagnosis of osteoporosis, but only 7.2% of them
were prescribed specific treatment [40].
Conclusions
The results of our cost-of-illness study show that osteo-
porosis is a costly disease with a significant financial
burden to the Austrian society. To improve the aware-
ness of osteoporosis being not only an economic prob-
lem, but also a determinant of quality of life in patients
affected, appropriate public health strategies need to be
applied. In this regard, the substantial socio-economic
burden resulting from osteoporotic fractures underlines
the importance of pharmacological treatment in those
who are at risk of osteoporosis, to prevent first and sub-
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